logo

Collplant Holdings Ltd (CLGN)



Trade CLGN now with
  Date
  Headline
3/29/2021 7:24:44 AM CollPlant Names Hugh Evans To Board
2/25/2021 9:22:30 AM CollPlant Receives Notice From Lung Biotechnology On Termination Of Licensing Agreement
2/8/2021 7:20:46 AM CollPlant In Deal With Allergan Aesthetics For RhCollagen In Dermal And Soft Tissue Filler Products
12/10/2020 7:44:08 AM CollPlant And STEMCELL Technologies Enter Product Manufacturing And Supply Agreement
12/1/2020 7:52:52 AM CollPlant Q3 Revenues $4.1 Mln Vs $679K Last Year
9/14/2020 7:21:36 AM CollPlant Inks Deal For Distribution Of Vergenix Flowable Gel Product In Six CIS Countries
8/28/2020 7:04:40 AM CollPlant Q2 Revenues Of $823,000, 36% Increase From Last Year
5/27/2020 7:08:56 AM CollPlant Biotechnologies Q1 Loss Per Share $0.24; Non-GAAP Loss Per Share $0.21
4/1/2020 7:08:32 AM CollPlant Biotechnologies FY Operating Loss $7.6 Mln Vs Loss $4.2 Mln Last Year
2/14/2020 7:07:59 AM CollPlant Biotechnologies Enters Definitive Agreements For Up To $4.45 Mln
2/10/2020 7:11:28 AM CollPlant Names Roger Pomerantz As Chairman Of Board Of Directors
12/19/2019 7:00:00 AM CollPlant Publishes Letter to Shareholders (Press Release)
11/29/2019 7:02:45 AM CollPlant Q3 Loss Per Share $0.69; Adj Loss Per Share $0.41
9/26/2019 7:07:09 AM CollPlant Q2 Comprehensive Loss $1.5 Mln Or $0.33/Shr Vs Loss Of $1.7 Mln Or $0.36/Shr Last Year
6/20/2019 8:11:21 AM CollPlant Holdings Ltd. Changes Names To CollPlant Biotechnologies Ltd
6/4/2019 7:19:42 AM CollPlant Says Clinical Results From Advanced Wound Care Product VergenixFG To Be Presented At EWMA